Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes.

Authors:
García-Ulloa AC; Pérez-Peralta L; Jaime-Casas S; Jiménez-Corona A; Rivera-De La Parra D and 3 more

Journal:
Diabetes Metab Syndr Obes

Publication Year: 2024

DOI:
10.2147/DMSO.S447658

PMCID:
PMC10799638

PMID:
38249155

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Diabetes Metab Syndr Obes

Abbreviation: Diabetes Metab Syndr Obes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology & Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass a…
Wang Y; Xu Y; Hu T and 5 more (2024) - Transparency Score: 3/6
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
Arshad MS; Alqahtani F; Rasool MF. (2024) - Transparency Score: 4/6
Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.
Guo C; Jiao M; Cui Y and 4 more (2024) - Transparency Score: 3/6
Clinical Evidence of the Relationship Between Alanine Aminotransferase and Diabetic Kidney Disease.
Bi Y; Yang Y; Yuan X and 4 more (2024) - Transparency Score: 3/6
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM.
Wang X; Liu X; Zhao J and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors report no conflicts of interest in this work."

Evidence found in paper:

"The CAIPaDi program has received grants from Astra Zeneca, Fundación Conde de Valenciana, Novartis, Consejo Nacional de Ciencia y Tecnología (“Proyectos de Desarrollo Científico para Atender Problemas Nacionales 2013 project 214718”), Nutrición Médica y Tecnología, Novo Nordisk, Boehringer Ingelheim, Dirección General de Calidad y Educación en Salud, Eli Lilly, Merck Serono, MSD, Silanes, Chinoin, and Carlos Slim Health Institute."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025